News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Parkinson’s Disease Cell Therapy Relieves Symptoms in Monkeys
Abby Olena | Aug 30, 2017
Neurons derived from human induced pluripotent stem cells fill in for lost dopamine neurons in a primate model of the disease.
Anna Azvolinsky | Dec 1, 2015
In his search for effective therapies for Parkinson’s disease, Lorenz Studer is uncovering pluripotency switches and clues to what makes cells age.
New Hope for Alzheimer’s Blood Test
Jef Akst | Oct 19, 2015
Using autoantibodies as biomarkers, researchers could soon identify people at the highest risk of developing neurodegenerative diseases much earlier than existing methods.
Why DBS Works for Parkinson’s?
Jef Akst | Apr 14, 2015
Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex.
23andMe, Genentech Partner on Parkinson’s
Tracy Vence | Jan 7, 2015
Firms enter a multi-year deal for the analysis of whole-genome sequence data, with an eye toward drug discovery for Parkinson’s disease.
CRISPR Pioneers Honored
Molly Sharlach | Nov 18, 2014
Influential researchers receive the 2015 Breakthrough Prizes in Life Sciences.
Metals on our Mind
Anthony White | Apr 1, 2014
A dramatic loss of copper in key brain regions may be central to Alzheimer’s disease. Could restoring metals in the brain help?
Abby Olena | Nov 1, 2013
Meet some of the people featured in the November 2013 issue of
New Shape of Parkinson's Protein
Kerry Grens | Aug 14, 2011
Evidence reshaping the structure of a protein linked to Parkinson’s suggests a new mechanism for the formation of the disease’s characteristic protein aggregates.
Nicotine Protects Against Parkinson’s?
Jef Akst | Aug 3, 2011
The addictive component of cigarettes saves dopamine neurons from a Parkinson's-like decline, providing a new avenue for potential treatment.